Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $217,230 | 105 | 99.1% |
| Travel and Lodging | $1,883 | 10 | 0.9% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Takeda Pharmaceuticals U.S.A., Inc. | $145,194 | 71 | $0 (2024) |
| Shire North American Group Inc | $73,919 | 44 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $32,242 | 17 | Takeda Pharmaceuticals U.S.A., Inc. ($32,242) |
| 2023 | $19,761 | 10 | Takeda Pharmaceuticals U.S.A., Inc. ($19,761) |
| 2022 | $41,132 | 18 | Takeda Pharmaceuticals U.S.A., Inc. ($41,132) |
| 2021 | $26,580 | 13 | Takeda Pharmaceuticals U.S.A., Inc. ($26,580) |
| 2020 | $25,480 | 13 | Takeda Pharmaceuticals U.S.A., Inc. ($25,480) |
| 2019 | $27,459 | 22 | Shire North American Group Inc ($27,459) |
| 2018 | $23,280 | 10 | Shire North American Group Inc ($23,280) |
| 2017 | $23,180 | 12 | Shire North American Group Inc ($23,180) |
All Payment Transactions
115 individual payment records from CMS Open Payments — Page 1 of 5
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/09/2024 | Takeda Pharmaceuticals U.S.A., Inc. | — | Consulting Fee | Cash or cash equivalent | $2,240.00 | General |
| 11/13/2024 | Takeda Pharmaceuticals U.S.A., Inc. | — | Consulting Fee | Cash or cash equivalent | $2,240.00 | General |
| 10/23/2024 | Takeda Pharmaceuticals U.S.A., Inc. | — | Consulting Fee | Cash or cash equivalent | $1,680.00 | General |
| 10/23/2024 | Takeda Pharmaceuticals U.S.A., Inc. | — | Travel and Lodging | In-kind items and services | $180.90 | General |
| 10/09/2024 | Takeda Pharmaceuticals U.S.A., Inc. | — | Consulting Fee | Cash or cash equivalent | $2,240.00 | General |
| 09/11/2024 | Takeda Pharmaceuticals U.S.A., Inc. | — | Consulting Fee | Cash or cash equivalent | $2,240.00 | General |
| 08/09/2024 | Takeda Pharmaceuticals U.S.A., Inc. | — | Consulting Fee | Cash or cash equivalent | $2,240.00 | General |
| 07/12/2024 | Takeda Pharmaceuticals U.S.A., Inc. | — | Consulting Fee | Cash or cash equivalent | $2,240.00 | General |
| 06/10/2024 | Takeda Pharmaceuticals U.S.A., Inc. | — | Consulting Fee | Cash or cash equivalent | $2,240.00 | General |
| 05/22/2024 | Takeda Pharmaceuticals U.S.A., Inc. | — | Consulting Fee | Cash or cash equivalent | $1,680.00 | General |
| 05/22/2024 | Takeda Pharmaceuticals U.S.A., Inc. | — | Travel and Lodging | In-kind items and services | $140.70 | General |
| 05/10/2024 | Takeda Pharmaceuticals U.S.A., Inc. | — | Consulting Fee | Cash or cash equivalent | $2,240.00 | General |
| 04/17/2024 | Takeda Pharmaceuticals U.S.A., Inc. | — | Consulting Fee | Cash or cash equivalent | $2,240.00 | General |
| 04/17/2024 | Takeda Pharmaceuticals U.S.A., Inc. | — | Consulting Fee | Cash or cash equivalent | $1,680.00 | General |
| 03/11/2024 | Takeda Pharmaceuticals U.S.A., Inc. | — | Consulting Fee | Cash or cash equivalent | $2,240.00 | General |
| 02/14/2024 | Takeda Pharmaceuticals U.S.A., Inc. | — | Consulting Fee | Cash or cash equivalent | $2,240.00 | General |
| 01/17/2024 | Takeda Pharmaceuticals U.S.A., Inc. | — | Consulting Fee | Cash or cash equivalent | $2,240.00 | General |
| 12/15/2023 | Takeda Pharmaceuticals U.S.A., Inc. | — | Consulting Fee | Cash or cash equivalent | $2,240.00 | General |
| 11/10/2023 | Takeda Pharmaceuticals U.S.A., Inc. | — | Consulting Fee | Cash or cash equivalent | $2,240.00 | General |
| 10/09/2023 | Takeda Pharmaceuticals U.S.A., Inc. | — | Consulting Fee | Cash or cash equivalent | $2,240.00 | General |
| 09/13/2023 | Takeda Pharmaceuticals U.S.A., Inc. | — | Consulting Fee | Cash or cash equivalent | $2,240.00 | General |
| 08/18/2023 | Takeda Pharmaceuticals U.S.A., Inc. | — | Consulting Fee | Cash or cash equivalent | $1,680.00 | General |
| 08/18/2023 | Takeda Pharmaceuticals U.S.A., Inc. | — | Travel and Lodging | In-kind items and services | $161.13 | General |
| 07/14/2023 | Takeda Pharmaceuticals U.S.A., Inc. | — | Consulting Fee | Cash or cash equivalent | $2,240.00 | General |
| 06/14/2023 | Takeda Pharmaceuticals U.S.A., Inc. | — | Consulting Fee | Cash or cash equivalent | $2,240.00 | General |
About Dr. James Kuplic, MD
Dr. James Kuplic, MD is a Internal Medicine healthcare provider based in Sheboygan, Wisconsin. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/10/2006. The National Provider Identifier (NPI) number assigned to this provider is 1598733909.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. James Kuplic, MD has received a total of $219,113 in payments from pharmaceutical and medical device companies, with $32,242 received in 2024. These payments were reported across 115 transactions from 2 companies. The most common payment nature is "Consulting Fee" ($217,230).
Practice Information
- Specialty Internal Medicine
- Location Sheboygan, WI
- Active Since 03/10/2006
- Last Updated 07/08/2007
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1598733909
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Sheboygan
Amir Patel, Md, MD
Internal Medicine — Payments: $55,953
Nikita Jain, Md, MD
Internal Medicine — Payments: $7,658
Dr. Vytas Kerpe, Md, MD
Internal Medicine — Payments: $7,388
Dr. Nicholas Barnes, Do, DO
Internal Medicine — Payments: $7,334
Dr. Michael Johnson, Md, MD
Internal Medicine — Payments: $7,308
Dr. Elizabeth Zurich, Do, DO
Internal Medicine — Payments: $7,242